Target intelligence / Profile preview

Physiological Plasma Components

Molecular classification
Other
01

Overview

“Physiological plasma components” refers to the diverse array of substances dissolved in blood plasma—including proteins (such as albumin, immunoglobulins, and clotting factors), electrolytes, hormones, metabolites, and waste products[1][3][5][7]. This combined mixture is not a drug target itself but provides essential functions: transporting nutrients and wastes, maintaining blood pressure and homeostasis, facilitating immune defense and blood clotting, and serving as biomarkers in many clinical conditions[1][3][4][6]. Some individual plasma proteins (such as clotting factors, albumin, and immunoglobulins) are isolated for therapeutic use or serve as direct drug targets or diagnostic biomarkers[4][6]. However, the term “physiological plasma components” is too broad and non-specific to be considered a molecular target in pharmacology.

Other names
Blood plasma componentsPlasma solutesPlasma proteins
02

Mechanism of action

Supplementation/replacement (e.g., giving albumin, immunoglobulins, or clotting factors to restore physiological levels); Modulation of immune response (via intravenous immunoglobulins); Management of oncotic pressure (e.g., albumin in shock/critical illness); Neutralization of toxins or pathogens (e.g., antibody therapies via plasma)

03

Biological functions

Transport of nutrients, hormones, and metabolic wasteImmune function (via antibodies)Blood clotting (via coagulation proteins)Maintenance of osmotic and oncotic pressureRegulation of fluid balanceSupport of cellular metabolismSupports homeostasis
04

Disease associations

Bleeding disorders (e.g., hemophilia)Immune deficienciesLiver diseaseCardiovascular diseaseInfectionsShock and traumaNeurodegenerative diseasesCancer (biomarkers or therapeutic targets in plasma)
05

Safety considerations

Risk of infection transmission in plasma-derived therapiesAllergic reactions to plasma proteinsVolume overload (in albumin therapy)Immunogenicity (immune response against foreign proteins)Transfusion-related complications (such as TRALI, TACO)Contraindications in certain comorbidities (e.g., heart failure)
06

Interacting drugs

Plasma protein therapies (includes albumin, immunoglobulins, clotting factor concentrates)

3 more in the full profile.

07

Biomarkers

Plasma proteins (albumin, fibrinogen, globulins, PSA, troponin, etc.) for diagnosis and monitoringSpecific antibodies for immune response assessmentClotting factors for bleeding disordersMetabolic markers (glucose, electrolytes)

Beyond the preview

Go deeper on Physiological Plasma Components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological Plasma Components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call